Twitter Beğeni Hilesi

Join us for the third edition of the Oncobell Symposium, "New Frontiers in #CancerTherapies and #PersonalizedMedicine," on October 3rd and 4th! More info ➡️ oncobellsymposium.idibell.cat

1. Read and write more. 2. Don't hesitate to admit when you're wrong. 3. Be comfortable changing your opinion. 4. Find a mentor. 5. Stay teachable. 6. Make mistakes and learn. 7. Don't get offended easily. 8. Ask questions. 9. Spend time with nature. 10. Stay humble.

🚭 En el #DíaMundialSinTabaco, nos hemos unido Fundación MÁS QUE IDEAS y Cáncer de Pulmón para divulgar y resolver algunos mitos y falsas creencias sobre el tabaquismo ⚠️ Recuerda: FUMAR NUNCA ES BUENA IDEA, ¡QUE NO TE ENGAÑEN! #PorUnMundoSinTabaco Abrimos hilo ⤵️⤵️⤵️

Join us to celebrate the discovery of the EGFR+ mutation that has revolutionised the treatment of EGFR+ lung cancer, giving us improved outcomes and hope. Today we also remember the ones that we have lost from our EGFR Resisters community.

Come join us next Friday at Campus Bellvitge UB for the defense of Sara Hijazo’s PhD thesis, directed by Ernest Nadal and Xavier Solé. She is re-defining lung cancer subtypes and developing new bioinformatic tools to predict responses. idibell.cat/agenda/thesis-…

Excelente mesa sobre ALK en la 3a edución de la reunión un paso más en el cáncer de pulmón charocampelo Edurne Arriola Noelia Vilariño Sefa Terrassa i Enric Carcereny

⭕️El cáncer de pulmón se convierte en la tercera causa de muerte en España. 👉🏼Tal y como recogen los datos del Observatorio de Cáncer de pulmón del GECP, un 87% de los casos son debidos al tabaquismo. ℹ️información: Informativos Telecinco 👉🏼 Enric Carcereny Bartomeu Massuti Fundación MÁS QUE IDEAS

Join us for this week's episode of #LungCancerConsidered as international clinicians Dr. Sarah Goldberg and Ernest Nadal discuss the unique characteristics of CNS metastases in patients with #NSCLC and #SCLC. ➡️ bit.ly/CNSMetastases

It was a pleasure to participate in this podcast with Dr Sarah Goldberg and Dr Narjust Florez, MD, FASCO centered on the management of CNS metastases in driver-negative NSCLC. Thanks to IASLC for dedicating a podcast to this special population. shar.es/agubzG

Scientists need more time to think acrobat.adobe.com/id/urn:aaid:sc… via nature

At 18, Grayson was diagnosed with lung cancer. This World Lung Cancer Day, he wants you to know that ANYONE with lungs can develop lung cancer 🫁🤍🌎

Very insightful and patient-centric paper. So much work ahead to mitigate inequalities across Europe and within most European countries.

"In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAFV600E lung adenocarcinoma" out on Cell Reports Medicine by our #OncoAlertAF 🚨Colleague Biagio Ricciuti, MD PhD 🇺🇸and Team sciencedirect.com/science/articl… This study investigates the vulnerabilities of

🌐 #BRN FORUM ACTUALIZACIÓN EN PATOLOGÍA PLEURAL ➡️ Actualización en el tratamiento local y sistémico del Mesotelioma Pleural Maligno 👩‍⚕️ Dr. Ernest Nadal (Institut Català d'Oncologia) 👇🧵

Riesgos para la salud de los vapeadores: ¡que no te vendan humo! blog.contraelcancer.es/riesgos-vapead…

lagestioimporta.cat/arees/investig…

Participar en el projecte LIFE ha estat una experiència molt enriquidora. La interacció amb els pacients fora de la clínica ens ha permés entendre millor les seves necessitats i prioritats. Gràcies a Cáncer de Pulmón, Xavier Bayona 🎗, Ana Sedano, Assumpta Company i a tots els que vau participar

#UniBarcelona | 💯 Commemorem els cent anys del naixement de Vicent Andrés Estellés. Els seus versos ens recorden qui som i ens connecten amb la nostra història i cultura. Fem que la seva obra ressoni avui i sempre! #CentDEstellés